Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Mammary Gland Biology and Neoplasia is Scopus-indexed (Q1, CiteScore 6.5), WoS SCIE. Published by Springer.
Checked against the index lists dated .
ISSN 1083-3021Verify ISSN ↗1573-7039Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$4,090 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 92 / 428 | 78th | Q1 |
| Cancer Research | 84 / 233 | 64th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q1, CiteScore 6.5.
Journal of Mammary Gland Biology and Neoplasia is Q1 in Oncology (rank 92 of 428) and Q2 in Cancer Research (rank 84 of 233), by CiteScore 2025.
Journal of Mammary Gland Biology and Neoplasia is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.5, which places it in quartile Q1 at the 78th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.764, quartile Q2, with an H-index of 117.
The publisher lists an article processing charge of about US$4,090 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Mammary Gland Biology and Neoplasia is published by Springer. Its print ISSN is 1083-3021 and its online ISSN is 1573-7039.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Mammary Gland Biology and Neoplasia has an h-index of 126 and a 2-year mean of 2.93 citations per paper (OpenAlex). Its Scopus CiteScore is 6.5, quartile Q1. On 2-year citations it ranks #117 of 424 Scopus journals in Oncology.
Journal of Mammary Gland Biology and Neoplasia published 19 papers in 2025; its busiest recent year was 2020 with 35. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2022–2026), authors are most often from United States (33.7%), United Kingdom (8.8%) and China (6.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (6.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.